Results 151 to 160 of about 8,165 (189)

Clinical and Comorbidity Profile of Clinically Diagnosed Gout in Two Tertiary Hospitals in Dubai, United Arab Emirates: A Retrospective Observational Study. [PDF]

Cureus
Abdullah S, Ali M, AlMadhloum AlSuwaidi SS, Negm A, Alzaabi M, Malik M, Ali K.   +6 more
europepmc   +1 more source

A systematic review and network meta-analysis of cardiovascular safety of benzbromarone compared to febuxostat and allopurinol in patients with gout. [PDF]

Front Cardiovasc Med
Lin TS, Lin YL, Hsu CH, Hsieh SC, Shau WY, Yang WS, Chen CL.   +6 more
europepmc   +1 more source

Time Trends and Predictors of Gout Remission Over 6 Years. [PDF]

Arthritis Care Res (Hoboken)
Tabi-Amponsah AD, Stewart S, Gamble G, Stamp LK, Taylor WJ, Dalbeth N.   +5 more
europepmc   +1 more source

Impact of Urate-Lowering Agents on Renal Outcomes in Chronic Kidney Disease: A Systematic Review. [PDF]

Cureus
Gafar Abubakir Osman H, Abderahim A, Ahmed Babiker MM, Mohammed Saied MH, Abdelrahman Elsheikh EE, Mohamed Mahmoud AE, Mohamed Ali HK.   +6 more
europepmc   +1 more source

Evaluatie van een elektronisch beslissingsondersteunend programma voor optimalisatie van het medicatieschema bij ambulante ouderen. [PDF]

, 2019
Christiaens, Thierry, Luyssen, Julie, Moerman, Hilde, Pauwelyn, Joke, Wauters, Maarten   +4 more
core   +1 more source

Xanthine Oxidase-Dependent Activation of NLPR3 Inflammasome in Epithelial Cells Sustains Inflammation in Inflammatory Bowel Disease. [PDF]

Inflamm Bowel Dis
Di Petrillo A, Fais A, Raho N, Era B, Cannea FB, Padiglia A, Grecu E, Murtas D, Maxia C, Sogos V, Porcedda C, Caboni P, Demurtas M, Favale A, Onali S, Fantini MC.   +15 more
europepmc   +1 more source

Increased Xanthine Oxidoreductase Activity in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. [PDF]

CHEST Pulm
Coursen JC, Tuhy T, Woods A, Hummers LK, Shah AA, Hassoun PM, Damico RL, Mathai SC, Simpson CE.   +8 more
europepmc   +1 more source

Effects of febuxostat on heart failure patients with asymptomatic hyperuricaemia: a retrospective cohort study. [PDF]

BMJ Open
Long X, Wang Z, Yuan W.
europepmc   +1 more source

Development of Bioresponsive Poloxamer-Based Self-Nanoemulsifying System for Enhanced Febuxostat Bioavailability: Solidification Strategy Using I-Optimal Approach. [PDF]

Pharmaceutics
Sherif AY, Elzayat EM.
europepmc   +1 more source

Hyperuricemia in Chronic Kidney Disease: Emerging Pathophysiology and a Novel Therapeutic Strategy. [PDF]

Int J Mol Sci
Takata T, Mae Y, Hoi S, Iyama T, Isomoto H.   +4 more
europepmc   +1 more source